News
A company that has Donald Trump Jr. on its board touted in a press release a new “initiative” to help pharmaceutical ...
Six months into Donald Trump’s second term, his administration is at war with the federal judiciary, evading court orders ...
Robert F. Kennedy Jr. has announced that his department will end funding for a series of mRNA-based vaccines aimed at ...
Pfizer ( PFE) shares gained on Tuesday after the New York-based pharma giant reported better-than-expected financials for Q2 2025 and increased its full-year earnings outlook, citing, among other ...
An official overseeing implementation of the Make America Healthy Again agenda at the Department of Health and Human Services ...
CSL Seqirus was one of the drugmakers the federal government listed this week as having its mRNA-related work cut. In an ...
SERB Pharmaceuticals plans to buy Y-mAbs Pharmaceuticals in a $412 million all-cash deal. CorMedix bought Melinta ...
The Department of Health and Human Services will cancel contracts and pull funding for some vaccines that are being developed ...
Eli Lilly stock dips despite strong Q2 results. Read my insights on obesity drug market dominance and why this selloff in LLY ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results